{{Rsnum
|rsid=79781594
|Chromosome=10
|Orientation=plus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=RET
|position=43113649
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=RET
}}{{omim
|id=164761
|rsnum=79781594
|variant=0008
}}{{ClinVar
|rsid=79781594
|Reversed=0
|FwdREF=G
|FwdALT=A,C,T
|REF=G
|ALT=A,C,T
|RSPOS=43609097
|CHROM=10
|dbSNPBuildID=131
|SSR=0
|SAO=1
|VP=0x050068000000000002110104
|GENEINFO=RET:5979
|GENE_NAME=RET
|GENE_ID=5979
|WGT=0
|VC=SNV
|CLNALLE=1; 2; 3
|CLNHGVS=NC_000010.10:g.43609097G>A; NC_000010.10:g.43609097G>C; NC_000010.10:g.43609097G>T
|CLNSRC=Emory University; OMIM Allelic Variant
|CLNORIGIN=0
|CLNSRCID=3872; 164761.0008
|CLNSIG=5
|CLNCUI=C0025268; C1833921
|CLNDBN=MEN2A and FMTC; Multiple endocrine neoplasia, type 2a; Familial medullary thyroid carcinoma; not provided
|Disease=MEN2A and FMTC; Multiple endocrine neoplasia; Familial medullary thyroid carcinoma; not provided
|CLNACC=RCV000021794.1; RCV000014933.24; RCV000014934.24; RCV000021791.1; RCV000082050.1; RCV000021795.1
|Tags=PM;PMC;OTHERKG;LSD;OM;NOV
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet:Orphanet:SNOMED_CT; GeneReviews:MedGen:OMIM:Orphanet
|CLNDSDBID=NBK1257:C0025268:171400:247698:653:61808009; NBK1257:C1833921:155240:653
}}{{PMID Auto
|PMID=8103403
|Title=Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
}}

{{PMID Auto
|PMID=7916559
|Title=Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
|OA=1
}}